CLA (CliftonLarsonAllen) Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,930
Closed -$743K 243
2021
Q3
$743K Sell
5,930
-34
-0.6% -$4.4K 0.03% 173
2021
Q2
$740K Buy
+5,964
New +$749K 0.03% 179
2019
Q4
Sell
-14,089
Closed -$1.53M 153
2019
Q3
$1.53M Buy
14,089
+3,921
+39% +$409K 0.13% 79
2019
Q2
$990K Sell
10,168
-1,954
-16% -$178K 0.1% 80
2019
Q1
$1.1M Buy
12,122
+874
+8% +$78.2K 0.12% 74
2018
Q4
$1.02M Buy
+11,248
New +$1.05M 0.1% 100
2017
Q4
Sell
-15,417
Closed -$1.2M 136
2017
Q3
$1.2M Buy
15,417
+437
+3% +$36.3K 0.13% 86
2017
Q2
$1.33M Sell
14,980
-1,533
-9% -$129K 0.15% 81
2017
Q1
$1.33M Buy
16,513
+3,826
+30% +$299K 0.15% 84
2016
Q4
$904K Buy
12,687
+1,794
+16% +$141K 0.1% 96
2016
Q3
$941K Buy
10,893
+634
+6% +$55.2K 0.11% 90
2016
Q2
$890K Sell
10,259
-3,085
-23% -$249K 0.13% 78
2016
Q1
$1M Buy
13,344
+1,021
+8% +$76.9K 0.16% 69
2015
Q4
$948K Sell
12,323
-1,216
-9% -$91.5K 0.16% 72
2015
Q3
$906K Buy
13,539
+1,686
+14% +$124K 0.17% 76
2015
Q2
$878K Hold
11,853
0.18% 72
2015
Q1
$924K Sell
11,853
-9,708
-45% -$736K 0.21% 62
2014
Q4
$1.56M Buy
21,561
+4,935
+30% +$343K 0.34% 41
2014
Q3
$1.03M Sell
16,626
-645
-4% -$41K 0.22% 52
2014
Q2
$1.1M Buy
17,271
+512
+3% +$31.1K 0.22% 55
2014
Q1
$1.03M Hold
16,759
0.23% 58
2013
Q4
$962K Sell
16,759
-481
-3% -$27.3K 0.24% 58
2013
Q3
$918K Buy
+17,240
New +$928K 0.25% 58

Other funds holding MDT

CLA (CliftonLarsonAllen) Wealth Advisors's MDT Position: Q4 2021 in Review

CLA (CliftonLarsonAllen) Wealth Advisors sold out of Medtronic (MDT) in Q4 2021, closing a stake of 5,930 shares — an estimated $743K sold.

CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in MDT in Q3 2013 and held it in 23 quarters. The position peaked at $1.56M in Q4 2014. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • CLA (CliftonLarsonAllen) Wealth Advisors reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • CLA (CliftonLarsonAllen) Wealth Advisors sold 5,930 Medtronic shares in Q4 2021, an estimated $743K.
  • CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in Medtronic in Q3 2013 and held it in 23 quarters.
  • CLA (CliftonLarsonAllen) Wealth Advisors's Medtronic position peaked at $1.56M in Q4 2014.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on CLA (CliftonLarsonAllen) Wealth Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.